Outcomes Associated With Potassium Abnormalities in CKD: It Is Time to Move to Clinical Trials
Am J Kidney Dis
.
2023 Sep;82(3):251-253.
doi: 10.1053/j.ajkd.2023.05.002.
Epub 2023 Jun 27.
Author
Csaba P Kovesdy
1
Affiliation
1
Division of Nephrology, Department of Medicine, University of Tennessee Health Science Center and Nephrology Section, Memphis VA Medical Center, Memphis, Tennessee. Electronic address: ckovesdy@uthsc.edu.
PMID:
37367714
DOI:
10.1053/j.ajkd.2023.05.002
No abstract available
Publication types
Editorial
Comment
MeSH terms
Clinical Trials as Topic
Humans
Hyperkalemia* / complications
Metabolic Diseases*
Potassium
Renal Insufficiency, Chronic* / complications
Renal Insufficiency, Chronic* / therapy
Substances
Potassium